Ellen B. Wright 🚀🐉📚 (@ellenbwright) / Twitter
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial - The Lancet
DjaneTop - We present the first real voting for the world's... | פייסבוק
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies | Nature
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis - Kidney International
Ellen Perez (@EllenPerez95) / Twitter
Recycling | Free Full-Text | How to Assess Product Performance in the Circular Economy? Proposed Requirements for the Design of a Circularity Measurement Framework | HTML
Full article: Pastoralists and peasants: perspectives on agrarian change
1910 Census, Sedgwick County KS - Ra-Rh
Ellen B. Wright 🚀🐉📚 (@ellenbwright) / Twitter
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality - Sletten - 2009 - Angewandte Chemie International Edition - Wiley Online Library
Lace Top – Tagged "L"– Understatement
Amazon | Turkish Music for Solo Violin | Cetiz / Jewett | 輸入盤 | ミュージック
Speakers - Masters of Digital 2022 - Hybrid Event - DIGITALEUROPE
No. 2 Stanford routs Utah 73-48 to win another Pac-12 title | | djournal.com
Linkwood 1997 Douglas of Drumlanrig 13 Year Old | Whisky Auctioneer
Editor's Choice – Diabetologia
Textiles and the environment: the role of design in Europe's circular economy — European Environment Agency
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children | NEJM
Differential effects of dietary fibres on colonic barrier function in elderly individuals with gastrointestinal symptoms | Scientific Reports
A phase III, randomized, placebo‐controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus - Furie - 2011 - Arthritis & Rheumatism - Wiley Online Library
First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial - Journal of Thoracic Oncology
Port Ellen 1982 Murray McDavid 27 Year Old | Whisky Auctioneer
